We are pleased to make available a couple presentations recorded during the scientific sessions at the 19th Annual John Goldman Conference on CML in Estoril. Presentations currently featured include response to front-line imatinib treatment in children and adolescents and factors affecting adherence in CML and ways to improvement. More presentations will be made available over the next couple of weeks.

Response to front-line imatinib treatment in children and adolescents with CML -
data from a large pediatric cohort
Meinolf Suttorp, University Hospital Dresden, Germany 

• Study design
• Hematological findings at diagnosis
• Imatinib dose, monitoring, and methods
• Cytogenetic response in patients with CML-CP
• Molecular response in patients with CML-CP
• Impairment of growth in pediatric patients on imatinib
• Probability of PFS in patients diagnosed in CML-CP
• Summary